4JKL

Crystal Structure of Streptococcus agalactiae beta-glucuronidase in space group P21212

4JKL の概要

• エントリーDOI: 10.2210/pdb4jkl/pdb
• 関連するPDBエントリー: 4JKK 4JKM
• 分子名称: Beta-glucuronidase, MAGNESIUM ION (3 entities in total)
• 機能のキーワード: alpha/beta barrel, beta-sandwich, sugar-binding domain, glycosyl hydrolase, hydrolase
• 由来する生物種: Streptococcus agalactiae
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 139609.17

構造登録者

Wallace, B.D.,Redinbo, M.R. (登録日: 2013-03-09, 公開日: 2014-09-17, 最終更新日: 2024-02-28)

主引用文献

Wallace, B.D.,Roberts, A.B.,Pollet, R.M.,Ingle, J.D.,Biernat, K.A.,Pellock, S.J.,Venkatesh, M.K.,Guthrie, L.,O'Neal, S.K.,Robinson, S.J.,Dollinger, M.,Figueroa, E.,McShane, S.R.,Cohen, R.D.,Jin, J.,Frye, S.V.,Zamboni, W.C.,Pepe-Ranney, C.,Mani, S.,Kelly, L.,Redinbo, M.R.
Structure and Inhibition of Microbiome beta-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.
Chem.Biol., 22:1238-1249, 2015

PubMed Abstract: The selective inhibition of bacterial β-glucuronidases was recently shown to alleviate drug-induced gastrointestinal toxicity in mice, including the damage caused by the widely used anticancer drug irinotecan. Here, we report crystal structures of representative β-glucuronidases from the Firmicutes Streptococcus agalactiae and Clostridium perfringens and the Proteobacterium Escherichia coli, and the characterization of a β-glucuronidase from the Bacteroidetes Bacteroides fragilis. While largely similar in structure, these enzymes exhibit marked differences in catalytic properties and propensities for inhibition, indicating that the microbiome maintains functional diversity in orthologous enzymes. Small changes in the structure of designed inhibitors can induce significant conformational changes in the β-glucuronidase active site. Finally, we establish that β-glucuronidase inhibition does not alter the serum pharmacokinetics of irinotecan or its metabolites in mice. Together, the data presented advance our in vitro and in vivo understanding of the microbial β-glucuronidases, a promising new set of targets for controlling drug-induced gastrointestinal toxicity.

PubMed: 26364932
DOI: 10.1016/j.chembiol.2015.08.005

実験手法

X-RAY DIFFRACTION (2.288 Å)